Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Tofacitinib | 0.3 | uM | 2 | MMP-3 | 49.0 | 49 | ||||
RA2159 | 2 | MMP-3 | 48.0 | 57 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 2 | MMP-3 | 45.0 | 63 | ||||
N2645 | 2 | MMP-3 | 33.0 | 60 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 2 | MMP-3 | 126.0 | 51 | ||||
RA2708 | 2 | MMP-3 | 80.5 | 30 | |||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | MMP-3 | 44.5 | 36 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | MMP-3 | 64.0 | 62 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | MMP-3 | 39.5 | 54 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | MMP-3 | 42.5 | 54 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | MMP-3 | 114.5 | 70 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | MMP-3 | 595.5 | 50 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | MMP-3 | 75.5 | 54 | |
RA2159 | TNF-a | 100 | ng/mL | 2 | MMP-3 | 123.5 | 54 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | MMP-3 | 107.0 | 59 | |
N2645 | TNF-a | 100 | ng/mL | 2 | MMP-3 | 121.5 | 60 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | MMP-3 | 6503.5 | 34 | |
RA2708 | TNF-a | 100 | ng/mL | 2 | MMP-3 | 4781.0 | 49 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | MMP-3 | 63.0 | 50 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | MMP-3 | 100.0 | 52 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | MMP-3 | 46.0 | 40 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | MMP-3 | 66.0 | 47 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | MMP-3 | 141.5 | 72 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | MMP-3 | 2210.0 | 61 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | MMP-3 | 1903.5 | 44 |